DWA
IDXX icon

Delos Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Delos Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$556 – 400
2023
Q4 		$556 Hold
1
– – ﹤0.01% 250
2023
Q3 		$512 Hold
1
– – ﹤0.01% 292
2023
Q2 		$503 Hold
1
– – ﹤0.01% 291
2023
Q1 		$501 Hold
1
– – ﹤0.01% 302
2022
Q4 		$408 Hold
1
– – ﹤0.01% 323
2022
Q3 		$0 Buy
+1
New +$367 ﹤0.01% 322

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Delos Wealth Advisors's IDXX Position: Q1 2024 in Review

Delos Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 1 share — an estimated $556 sold.

Delos Wealth Advisors first reported a position in IDXX in Q3 2022 and held it in 6 quarters. The position peaked at $556 in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Delos Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Delos Wealth Advisors sold 1 Idexx Laboratories share in Q1 2024, an estimated $556.
  • Delos Wealth Advisors first reported a position in Idexx Laboratories in Q3 2022 and held it in 6 quarters.
  • Delos Wealth Advisors's Idexx Laboratories position peaked at $556 in Q4 2023.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Delos Wealth Advisors's 13F filing for Q1 2024, filed 9 May 2024.